Comparative Pharmacology
Head-to-head clinical analysis: ATORVALIQ versus SIMVASTATIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ATORVALIQ versus SIMVASTATIN.
ATORVALIQ vs SIMVASTATIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
ATORVALIQ is a combination of atorvastatin and amlodipine. Atorvastatin is an HMG-CoA reductase inhibitor that decreases cholesterol synthesis in the liver. Amlodipine is a calcium channel blocker that inhibits calcium ion influx across cardiac and vascular smooth muscle, causing vasodilation.
Competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Reduces hepatic cholesterol synthesis, increases LDL receptor expression, and lowers plasma LDL cholesterol.
10-80 mg orally once daily. Starting dose 10-20 mg. Max dose 80 mg.
10-40 mg orally once daily in the evening; maximum 80 mg/day.
None Documented
None Documented
Clinical Note
moderateSimvastatin + Levofloxacin
"The serum concentration of Levofloxacin can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Norfloxacin
"The serum concentration of Norfloxacin can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Prednisolone
"The serum concentration of Prednisolone can be increased when it is combined with Simvastatin."
Clinical Note
moderateSimvastatin + Resveratrol
The terminal elimination half-life of atorvastatin is approximately 14 hours; however, its active metabolites have a half-life of 20-30 hours, allowing for once-daily dosing.
The terminal elimination half-life of simvastatin is approximately 2-3 hours, but for the active metabolite (simvastatin acid) it is about 1.9 hours; clinical lipid-lowering effects persist longer due to sustained HMG-CoA reductase inhibition.
Atorvastatin is primarily eliminated via biliary/fecal excretion (approximately 70% as metabolites), with renal excretion accounting for less than 2% of the administered dose.
Primarily hepatic metabolism, with approximately 13% excreted in urine as metabolites and 60% in feces via biliary elimination; less than 0.5% of the active form is excreted unchanged in urine.
Category C
Category D/X
Statin
Statin
"The serum concentration of Resveratrol can be increased when it is combined with Simvastatin."